Dr. Paul MacKoul, MD, a leader in gynecologic surgery, develops "Value Based Care" innovations to provide the best care at the lowest cost. Dr. MacKoul co-founded the Center for Innovative GYN Care, which pioneers "new procedural technology" for freestanding surgery centers. Tower Surgical Partners, which expands single-specialty GYN surgery centers, is led by him.
To "change the landscape" in any field of surgery, new techniques and procedures must first be exposed to current methods, then adapted and changed to improve outcomes. Dr. MacKoul needed a fellowship in Gynecological Oncology to master surgery. GYN Oncology is the highest level of surgical training for complex gynecological issues and cancers. GYN Oncology training prepares for surgery because OBGYNs focus on obstetrics.
After his fellowship, Dr. MacKoul worked with several experienced GYN oncologists and became the Director, Gynecologic Oncology at Washington Hospital Center (WHC) in Washington, DC. WHC, a prominent inner city facility, had to care for many uninsured patients with complex medical and social issues. Dr. MacKoul focused on laparoscopic surgery to avoid large incisions. New surgical techniques allowed cancer patients with complex surgical challenges to leave the hospital the same day, recover faster, and start treatment sooner than if they had "open" surgery with more pain and recovery time.
Division Director, Gynecological Oncology at the George Washington University Medical Center in downtown Washington, DC, was his next career move. Dr. MacKoul directed minimally invasive GYN surgery at Holy Cross Hospital in Silver Spring, Maryland, a GW Medical Center affiliate. Dr. MacKoul taught residents new procedures that reduced recovery time, pain, complications, and cost for women.
Dr. MacKoul published and discussed his results nationally and internationally as surgical outcomes improved. The procedures were praised by CNN, ABC, KSN, Bloomberg News, and HuffPost.
Dr. MacKoul and Dr. Danilyants developed DualportGYN to treat endometriosis, pelvic masses, and hysterectomy. In a comparison of 2600+ patients between robotics, laparoscopic, and vaginal hysterectomy, DualportGYN had the fastest recovery, lowest complications, and lowest cost in the literature. DualportGYN saved $5,000 over a robotic hysterectomy. DualportGYN data was published in major peer-reviewed journals and presented at national conferences.
DualportGYN successfully excised endometriosis. Retroperitoneal dissection, used by DualportGYN, removes all illness while fully exposing and avoiding harm to surrounding structures and significantly reducing complications. Endometriosis patients now have a better, less invasive, faster, and cheaper surgical option than several incisions with robotics.
LAAM Fibroid surgery, created after DualportGYN, was even more innovative. LAAM fibroid ectomy preserved the uterus for fertilization. LAAM removed fibroid without a huge open incision or an expensive and tedious Robot, which increased complications, incisions, and cost. LAAM removed fibroids of any size in the uterus with only two incisions and sent patients home the same day. LAAM was perfected over thousands of cases and reported in a comparison study vs. robotics, open, and laparoscopic techniques, revealing the lowest complication rates and fastest recovery.
LAAM safely removes more uterine fibroids than laparoscopic and robotic surgery. US conferences have featured LAAM.
Dr. MacKoul's two highly effective and robust surgical techniques for hysterectomy, fibroid removal, and endometriosis, proved that the procedure could be done "outpatient," meaning patients returned home the same day. The operations' safety and efficacy were established, and it was evident that they could be conducted in a freestanding surgery center outside the hospital.
Freestanding GYN surgery centers only benefit patients and the healthcare system. The surgery center's "emphasis" on GYN surgery improves care and patient satisfaction. Care quality and complications improve. Freestanding surgery centers cost 60% less than hospitals. This saved money when compared to robotics or other methods.
Dr. Paul MacKoul, MD founded Rockville's first ASC, Tower Surgical Partners. Maryland and Secaucus, NJ, opened second and third. These ASCs are "state of the art" with the best equipment and optics, the highest safety profile, especially educated staff, "cell savers" that avoid transfusion, the lowest infection rates, and an atmosphere conducive to the highest quality GYN surgery.
Dr. MacKoul has always prioritized value-based care. Powerful and novel procedures like DualportGYN and LAAM Fibroid surgery reduce problems, improve outcomes, and cut costs. DualportGYN and LAAM Fibroids performed well in non-hospital ASCs due to safety and efficacy. The "transition" from the hospital to the freestanding ASC improved results and drastically reduced surgery expenses. Reduced costs help patients, doctors, insurers, and the healthcare system function better.
To provide the most excellent care at the lowest cost, all GYN surgeons should learn and develop DualportGYN and LAAM Fibroids. Dr. MacKoul's goal is to teach doctors and give patients access to ASCs to advance this Value-Based Care approach to GYN surgery.
To "change the landscape" in any field of surgery, new techniques and procedures must first be exposed to current methods, then adapted and changed to improve outcomes. Dr. MacKoul needed a fellowship in Gynecological Oncology to master surgery. GYN Oncology is the highest level of surgical training for complex gynecological issues and cancers. GYN Oncology training prepares for surgery because OBGYNs focus on obstetrics.
After his fellowship, Dr. MacKoul worked with several experienced GYN oncologists and became the Director, Gynecologic Oncology at Washington Hospital Center (WHC) in Washington, DC. WHC, a prominent inner city facility, had to care for many uninsured patients with complex medical and social issues. Dr. MacKoul focused on laparoscopic surgery to avoid large incisions. New surgical techniques allowed cancer patients with complex surgical challenges to leave the hospital the same day, recover faster, and start treatment sooner than if they had "open" surgery with more pain and recovery time.
Division Director, Gynecological Oncology at the George Washington University Medical Center in downtown Washington, DC, was his next career move. Dr. MacKoul directed minimally invasive GYN surgery at Holy Cross Hospital in Silver Spring, Maryland, a GW Medical Center affiliate. Dr. MacKoul taught residents new procedures that reduced recovery time, pain, complications, and cost for women.
Dr. MacKoul published and discussed his results nationally and internationally as surgical outcomes improved. The procedures were praised by CNN, ABC, KSN, Bloomberg News, and HuffPost.
Dr. MacKoul and Dr. Danilyants developed DualportGYN to treat endometriosis, pelvic masses, and hysterectomy. In a comparison of 2600+ patients between robotics, laparoscopic, and vaginal hysterectomy, DualportGYN had the fastest recovery, lowest complications, and lowest cost in the literature. DualportGYN saved $5,000 over a robotic hysterectomy. DualportGYN data was published in major peer-reviewed journals and presented at national conferences.
DualportGYN successfully excised endometriosis. Retroperitoneal dissection, used by DualportGYN, removes all illness while fully exposing and avoiding harm to surrounding structures and significantly reducing complications. Endometriosis patients now have a better, less invasive, faster, and cheaper surgical option than several incisions with robotics.
LAAM Fibroid surgery, created after DualportGYN, was even more innovative. LAAM fibroid ectomy preserved the uterus for fertilization. LAAM removed fibroid without a huge open incision or an expensive and tedious Robot, which increased complications, incisions, and cost. LAAM removed fibroids of any size in the uterus with only two incisions and sent patients home the same day. LAAM was perfected over thousands of cases and reported in a comparison study vs. robotics, open, and laparoscopic techniques, revealing the lowest complication rates and fastest recovery.
LAAM safely removes more uterine fibroids than laparoscopic and robotic surgery. US conferences have featured LAAM.
Dr. MacKoul's two highly effective and robust surgical techniques for hysterectomy, fibroid removal, and endometriosis, proved that the procedure could be done "outpatient," meaning patients returned home the same day. The operations' safety and efficacy were established, and it was evident that they could be conducted in a freestanding surgery center outside the hospital.
Freestanding GYN surgery centers only benefit patients and the healthcare system. The surgery center's "emphasis" on GYN surgery improves care and patient satisfaction. Care quality and complications improve. Freestanding surgery centers cost 60% less than hospitals. This saved money when compared to robotics or other methods.
Dr. Paul MacKoul, MD founded Rockville's first ASC, Tower Surgical Partners. Maryland and Secaucus, NJ, opened second and third. These ASCs are "state of the art" with the best equipment and optics, the highest safety profile, especially educated staff, "cell savers" that avoid transfusion, the lowest infection rates, and an atmosphere conducive to the highest quality GYN surgery.
Dr. MacKoul has always prioritized value-based care. Powerful and novel procedures like DualportGYN and LAAM Fibroid surgery reduce problems, improve outcomes, and cut costs. DualportGYN and LAAM Fibroids performed well in non-hospital ASCs due to safety and efficacy. The "transition" from the hospital to the freestanding ASC improved results and drastically reduced surgery expenses. Reduced costs help patients, doctors, insurers, and the healthcare system function better.
To provide the most excellent care at the lowest cost, all GYN surgeons should learn and develop DualportGYN and LAAM Fibroids. Dr. MacKoul's goal is to teach doctors and give patients access to ASCs to advance this Value-Based Care approach to GYN surgery.